ArticleClinical proteomics2015

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.

Henrik J Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.